Searchable abstracts of presentations at key conferences in endocrinology

ea0011p292 | Diabetes, metabolism and cardiovascular | ECE2006

Glucose metabolism, insulin secretion and insulin sensitivity in juvenile hemochromatosis

Angelopoulos N , Noutsou M , Goula A , Tolis G

Among specific diabetes subtypes secondary to pancreatopathies, hereditary hemochromatosis is an inherited disorder of iron metabolism, resulting to excessive iron overload and tissue damage in various organs. We report here the case of a man with the young-onset form of the disease and we describe his glycaemic status, before and during venesection therapy. A 25-year-old man attended our clinic in Athens, Greece, with hypogonadotropic hypogonadism due to hereditary hemochroma...

ea0090p763 | Thyroid | ECE2023

Long term effects of 0.1 mg Recombinant Human Thyrotropin-Stimulated fix dose of radioiodine therapy in patients with recurrent multinodular goiter after surgery. A 10 year follow-up study

Angelopoulos Nikolaos , Iakovou Ioannis , Effraimidis Grigoris , Livadas Sarantis

Background: Several treatment options exist after thyroid malignancy has been ruled out in patients with multinodular goiter (MG). Surgery efficiently reduces the goiter size but carries a risk of both surgical and anesthetic complications while in recent years, levothyroxine suppressive therapy has been abounded. I131 therapy is the only nonsurgical alternative; however, the effectiveness diminishes with increasing goiter size and depends on iodine sufficiency in some areas. ...

ea0090ep215 | Calcium and Bone | ECE2023

Short-term treatment with 2000IU of cholecalciferol in patients with secondary hyperparathyroidism due to vitamin d insufficiency

Angelopoulos Nikolaos , Boniakos Anastasios , Karras Spyridon , Paparodis Rodis , Livadas Sarantis

Introduction: Conventional treatment of secondary hyperparathyroidism (SHP) requires supplementation of vitamin d analogues combined with calcium however several studies have reported concerns regarding the safety of calcium supplements particularly in the long term. If vitamin d without concomitant calcium supplementation is sufficient to prompt a fall in the parathyroid hormone (PTH) is still not known with certainty. The purpose of our study was to investigate if vitamin d ...

ea0081p232 | Thyroid | ECE2022

Levothyroxine Replacement Therapy overuse. Factors suggesting treatment discontinuation

Livadas Sarantis , Bothou Christina , Paparodis Rodis , Androulakis Ioannis , Angelopoulos Nicholas , Boniakos Anastasios , Anagnostis Panagiotis , Duntas Leonidas

Background: Levothyroxine (LT4-Rx) is one of the most prescribed drugs worldwide and the vast majority of patients receive long-term treatment. However, in a recent study of 291 subjects we found that 60% of this cohort were euthyroid two months after LT4-Rx discontinuation1.Aim of the study: A prospective clinical cohort follow-up study was carried out. In 688 subjects (82% females) aged 48.01±15.96 (range 17-84years) with 8.59±6.98...

ea0084op-06-30 | Oral Session 6: Hypothyroidism | ETA2022

Levothyroxine replacement therapy overuse and factors guiding successful treatment discontinuation: short and long-term observation data of a large cohort

Livadas Sarantis , Androulakis Ioannis , Angelopoulos Nikolaos , Anagnostis Panagiotis , Paparodis Rodis , Boniakos Anastasios , Askitis Dimitrios , Duntas Leonidas

Background: Levothyroxine (LT4Rx) is one of the most prescribed drugs worldwide the vast majority of patients receive long-term treatment. However, in a recent study of 291 subjects, it was found that 60% were euthyroid 2 months after LT4-Rx discontinuation1.Aim of the study: A prospective clinical cohort follow-up study was carried out. In 688 subjects (82% females) aged 48.01±15.96 (range 17-84years) with 8.59±6.98 years on LT4Rx witho...

ea0090p508 | Thyroid | ECE2023

The clinical significance of low dose biotin supplements (<300μg/day) in the treatment of patients with hypothyroidism: crucial or overestimated?

Angelopoulos Nikolaos , Paparodis Rodis , Androulakis Ioannis , Boniakos Anastasios , Karras Spyridon , Livadas Sarantis

Background: In the last decade, the combination of the widespread use of streptavidin-biotin technology and biotin–containing supplements (BCS) in the daily clinical practice, have led to numerous reports of erroneous hormone immunoassay results. However, there are no studies assessing the clinical and biochemical significance of that phenomenon, when treating patients with hypothyroidism. Therefore, a prospective study was designed to investigate the potential alteration...

ea0049oc4.5 | Thyroid Disease 1 | ECE2017

Levothyroxine replacement therapy: once treatment is started, should it last indefinitely?

Livadas Sarantis , Bothou Christina , Androulakis Ioannis , Boniakos Anastasios , Angelopoulos Nicholas , Duntas Leonidas

Background: Levothyroxine (LT4) is one of the most prescribed drugs worldwide. Once started, about 90% of patients continue LT4 treatment long-term.Aim of the study: To evaluate the necessity of long-term thyroxine supplementation and to determine the prognostic factors that could identify which patients may discontinue LT4 treatment.Design and methods: LT4 replacement therapy was paused for at least six weeks in all patients conse...

ea0020p544 | Neuroendocrinology, Pituitary and Behaviour | ECE2009

The effects of selective serotononin reuptake inhibitors on the thyroid axis in perimenopausal depression

Karaoulanis Sokratis , Rizoulis Andreas , Lalios Georgios , Damani Eleni , Rizouli Katerina , Liakos Nikos , Papadimitriou Alexandros , Angelopoulos Nikiforos

Introduction: There is a great interest in the association of thyroid hormones and mood. Although it appears to be important interactions between the central regulation of mood and the thyroid axis, the effects of antidepressants and especially of selective serotonin reuptake inhibitors (SSRIs) remain ambiguous. We investigated the thyroid function in perimenopausal women suffering from depression.Material and methods: We examined 102 perimenopausal wome...

ea0020p578 | Neuroendocrinology, Pituitary and Behaviour | ECE2009

Association of Interleukin-6 with hot flashes in perimenopausal women

Karaoulanis Sokratis , Rizouli Katerina , Rizoulis Andreas , Lalios Georgios , Theodoridou Katerina , Angelopoulos Nikiforos V

Introduction: Hot flashes and night sweating are the most common medical complaints in women during the menopausal transition and they are strongly associated with the presence of perimenopausal depression. The pathophysiology of hot flashes has not been elucidated. Peripheral vasodilation and increase in skin temperature observed in women with hot flashes might be induced by changes in brain neurotransmitters and instability in the hypothalamic thermoregulatory center due to ...

ea0011p6 | Bone | ECE2006

Circulating osteoprotegerin and receptor activator of NF- κB ligand system in patients with beta-thalassemia major

Angelopoulos N , Rombopoulos G , Kaltsas D , Kaltzidou V , Katounda E , Tolis G

Objectives: To characterize the possible role of the osteoprotegerin (OPG) and receptor activator of NF-κB ligand (RANKL) system in thalassemia-related bone loss.Background: Osteoporosis represents an important cause of morbidity in patients with β-thalassemia major and its aetiology is multifactorial.Methods: Serum concentrations of OPG, RANKL, markers of bone turnover and lumbar spine bone mineral density (BMD) were mea...